Genetic Testing Could Reshape Emergency Prescribing, but the Evidence Is Not There Yet
A new perspective argues that pharmacogenomic testing could improve emergency department prescribing, but no randomized controlled trials have yet tested ...
Tag: CYP2C19
Research report: Estimating metabolic pathway overlap in precision oncology: integrating pharmacogenetics and polypharmacy
Only a small fraction of the drugs recommended for gastrointestinal cancers are directly steered by known pharmacogenetic variants, yet the ...
Model finds CYP2C19-guided DAPT cost-effective after PCI
A 40-year NHS cost-effectiveness model estimated that CYP2C19-guided dual antiplatelet therapy after PCI was likely cost-effective for STEMI and UA/NSTEMI ...
Cheap Two-Pill Combo Halves Early Stroke Worsening in Landmark Chinese Trial
A multicenter Chinese randomized trial found that low-dose ticagrelor plus aspirin halved early neurological deterioration after high-risk minor stroke compared ...
CYP2C9 & CYP2C19 Impact on CBD Metabolism
In a groundbreaking study poised to reshape our understanding of cannabis consumption and metabolism, researchers have unveiled the pivotal role ...
POPULAR NEWS
-
Case Report Explores Caplacizumab in Late-Diagnosed Congenital Thrombotic Thrombocytopenic Purpura
-
Multitask Cambrian Model Improves Protein Melting Temperature Prediction
-
Vasopressors Exert Divergent Immunomodulatory Effects Across a Spectrum in Septic Shock
-
Study Identifies Key Drivers Shaping Salmonid Gill Microbiomes in Aquaculture